Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 ('Act') in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigarh Bench of the Hon''ble National Company Law Tribunal at Chandigarh ('Order'), separate meetings of the unsecured creditors and equity shareholders of GlaxoSmithKline Consumer Healthcare Limited ("Company") are being convened at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha - 147201, Punjab on Saturday, June 1, 2019, at 10:00 A.M. and 12:00 Noon, respectively ("Meetings"), for the purpose of considering and, if thought fit, approving with or without modification(s), the scheme of amalgamation among the Company and Hindustan Unilever Limited and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Act. In this regard, please find enclosed the copy of the newspaper publications with respect to the advertisement of the Notices of the Meetings. The advertisements have been published in Financial Express (English), Punjab edition, dated April 24, 2019 and Punjabi Tribune (Punjabi), Chandigarh edition, dated April 25, 2019, pursuant to the directions contained in the Order.